title: Glycated hemoglobin A₁c (HbA₁c) and diabetes: a new era?
abstract: Abstract   In January 2011 the American Diabetes Association (ADA) published the latest guidelines for the diagnosis and treatment of diabetes mellitus (DM)(1,2). Despite some controversies, glycated hemoglobin A(1c) (HbA(1c)), an established marker of long-term glycemia traditionally used to assess the quality of DM management, remained an independent criterion for the diagnosis of DM, and indeed now appears to be well established in the USA. This has far-reaching implications for clinical practice worldwide.
authors.forename: Niki
authors.initials: N
authors.lastname: Katsiki
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Papanas
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: Vivian A
authors.initials: VA
authors.lastname: Fonseca
mesh_terms: D003920:Diabetes Mellitus / Q000175:diagnosis* / Q000628:therapy*; D005260:Female; D006442:Glycated Hemoglobin; D006031:Glycosylation; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014481:United States
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human